Secretion of vascular endothelial growth factor vascular permeability factor from human luteinized granulosa cells is human chorionic gonadotrophin dependent

被引:68
作者
Neulen, J [1 ]
Raczek, S
Pogorzelski, M
Grunwald, K
Yeo, TK
Dvorak, HF
Weich, HA
Breckwoldt, M
机构
[1] Univ Clin, Rhein Westfal TH Aachen, Dept Gynaecol Endocrinol & Reprod Med, D-52074 Aachen, Germany
[2] Univ Freiburg, Frauenklin, D-79106 Freiburg, Germany
[3] Beth Israel Hosp, Harvard Med Sch, Boston, MA 02215 USA
[4] Gesell Biotechnol Forsch GmbH, D-38124 Braunschweig, Germany
关键词
granulosa cells; ovarian hyperstimulation syndrome; vascular endothelial growth factor; vascular permeability factor;
D O I
10.1093/molehr/4.3.203
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Vascularization is a prominent event during corpus luteum formation, providing low density lipoproteins for steroid biosynthesis and enabling transport of secreted steroids, The process of vascularization is controlled by specific regulators. Vascular endothelial growth factor (VEGF), otherwise named vascular permeability factor (VPF), induces endothelial cell proliferation as well as angiogenesis in vivo and increases capillary permeability. Here we report the expression of VEGF/VPF mRNA by cultured human luteinized granulosa cells (GC) for at least 10 days. Without HCG VEGF/VPF expression declined after day 4 and by day 10 was reduced to similar to 30% of the value at day 4. However, after culture in the presence of 1 U/ml human chorionic gonadotrophin (HCG), expression of VEGF/VPF mRNA by GC was four times greater than control experiments by day 10, and increased 100% from day 4 to day 10. Simultaneously, HCG supplementation increased VEGF/VPF secretion by GC. Medium VEGF/VPF on day 3 was 13 pM without and 11 pM with HCG. Medium VEGF/VPF on day 10 was 6 pM without HCG and 29 pM with HCG. These results suggest that vascularization of the corpus luteum is induced by HCG-mediated effects of VEGF/VPF.
引用
收藏
页码:203 / 206
页数:4
相关论文
共 41 条
[21]   VASCULAR ENDOTHELIAL GROWTH-FACTOR IS A SECRETED ANGIOGENIC MITOGEN [J].
LEUNG, DW ;
CACHIANES, G ;
KUANG, WJ ;
GOEDDEL, DV ;
FERRARA, N .
SCIENCE, 1989, 246 (4935) :1306-1309
[22]  
Manaka C, 1995, JPN J FERTIL STERIL, V40, P427
[23]  
Marsepoil T, 1992, Rev Fr Gynecol Obstet, V87, P148
[24]  
Mathur R. S., 1995, Acta Geneticae Medicae et Gemellologiae, V44, P233
[25]   VASCULAR ENDOTHELIAL GROWTH-FACTOR AS CAPILLARY-PERMEABILITY AGENT IN OVARIAN HYPERSTIMULATION SYNDROME [J].
MCCLURE, N ;
HEALY, DL ;
ROGERS, PAW ;
SULLIVAN, J ;
BEATON, L ;
HANING, RV ;
CONNOLLY, DT ;
ROBERTSON, DM .
LANCET, 1994, 344 (8917) :235-236
[26]   LUTEAL PHASE SUPPORT AND SEVERE OVARIAN HYPERSTIMULATION SYNDROME [J].
MCCLURE, N ;
LEYA, J ;
RADWANSKA, E ;
RAWLINS, R ;
HANING, RV .
HUMAN REPRODUCTION, 1992, 7 (06) :758-764
[27]   PREDICTIVE VALUE OF SERUM ESTRADIOL CONCENTRATIONS AND OOCYTE NUMBER IN SEVERE OVARIAN HYPERSTIMULATION SYNDROME [J].
MORRIS, RS ;
PAULSON, RJ ;
SAUER, MV ;
LOBO, RA .
HUMAN REPRODUCTION, 1995, 10 (04) :811-814
[28]   HUMAN CHORIONIC GONADOTROPIN-DEPENDENT EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR VASCULAR-PERMEABILITY FACTOR IN HUMAN GRANULOSA-CELLS - IMPORTANCE IN OVARIAN HYPERSTIMULATION SYNDROME [J].
NEULEN, J ;
YAN, ZP ;
RACZEK, S ;
WEINDEL, K ;
KECK, C ;
WEICH, HA ;
MARME, D ;
BRECKWOLDT, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (06) :1967-1971
[29]   VASCULAR ENDOTHELIAL GROWTH-FACTOR IS EXPRESSED IN RAT CORPUS-LUTEUM [J].
PHILLIPS, HS ;
HAINS, J ;
LEUNG, DW ;
FERRARA, N .
ENDOCRINOLOGY, 1990, 127 (02) :965-967
[30]   HUMAN MENOPAUSAL GONADOTROPINS FOR ANOVULATION AND STERILITY - RESULTS OF 7 YEARS OF TREATMENT [J].
RABAU, E ;
DAVID, A ;
SERR, DM ;
MASCHIAC.S ;
LUNENFELD, B .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1967, 98 (01) :92-+